Follow Us

Global Nasal Spray Market Size, Segmentation, Trends and Growth Analysis Forecast by 2030

  •   DLR4872
  •   April, 2024
  •   Pages: 150
  •  Global

Nasal Spray Market Overview and Analysis:

The Nasal Spray Market was currently valued at USD 10.7 billion in the year 2022 registering a CAGR of 6.1% over the forecast period, 2023-2030. 

Nasal Spray Market

Get Complete Analysis Of The Report - Download Free Sample PDF

Nasal sprays are used to provide drugs locally or systemically to the nasal cavities. Localized problems like nasal congestion and allergic rhinitis are treated with the help of nasal spray. Because it offers a more palatable option than an injection or pill, the nasal administration route may be chosen for systemic therapy in some circumstances.

The increasing prevalence of asthma and COPD and the availability of low-cost generic drugs are also significant factors driving the market growth. The global population is getting old rapidly, owing to reduced birth rates and increasing life expectancy. Rapid urbanization in several countries and a large amount of pollution have contributed to a higher rate of respiratory diseases globally. 

Segmentation:

The Nasal Spray Market is Segmented

By Drug Class :

  • Corticosteroids
  • Bronchodilators
  • Antihistamines
  • Decongestant Sprays
  • Other Drug Classes 

Application :

  • Asthma
  • COPD
  • Allergic Rhinitis
  • Other Applications

Geography :

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East
  • Africa

The report offers the value in USD million for the above segments.

Nasal Spray Market Segmentation

For Detailed Market Segmentation - Download Free Sample PDF

Drivers:

Growth and Innovations in the Pharmaceutical Industry for the Manufacturing of Nasal Spray Products Owing to a Massive Pool of Health-Conscious Consumers

The launch of new products by key market players is fuelling the growth of the studied market. For instance, in February 2022, Glenmark Pharmaceuticals Limited (Glenmark) and Canadian pharmaceutical company SaNOtize Research & Development Corp. today announced the launch of its Nitric Oxide Nasal Spray under the brand name FabiSpray in India for the treatment of adult patients with COVID-19 who have a high risk of progression of the disease.

The Increasing Prevalence of Asthma and COPD and The Availability of Low-Cost Generic Drugs Are Also Significant Factors Driving The Market Growth.

The global population is getting old rapidly, owing to reduced birth rates and increasing life expectancy. Rapid urbanization in several countries and a large amount of pollution have contributed to a higher rate of respiratory diseases globally. For instance, as per the article published in 2022 by EGU journal, urbanization influences air pollutants through urban development and emission growth and increases health risks. Rapidly growing economies tend to have more urbanization, thereby high chances of air pollution leading to airway and respiratory issues. In such a scenario, the utilization of inhalation and nasal spray generic drugs is expected to boost market growth.

Restraints:

Strict Government Regulations Associated with Generic Respiratory Drugs Restrain

The strict government regulations associated with generic respiratory drugs may slow down the growth of the studied market. Most of these products are sold only under prescription-based drugs.

COVID-19 Impact on Nasal Spray Market

COVID-19 had a notable impact on the inhalation and nasal spray generic drugs market, as one of the main symptoms associated with COVID-19 is shortness of breath. During the pandemic, the demand for inhalation and nasal spray increased. For instance, an article published by NCBI in February 2023, reported that A nitric oxide nasal spray (NON) manufactured by SaNOtize was found to reduce COVID-19 viral loads to significant levels in patients. Thus, such instances show that the demand for nasal spray significantly increased during COVID-19, however with the subsequent decrease in COVID-19 cases, the demand for nasal spray market is expected to become stabilized compared to the beginning of the pandemic. It is estimated due to the other benefits offered by the nasal spray, the demand for the studied market is expected to increase over the forecast period.

Segmental Analysis :

Asthma Holds Significant Share in the Global Inhalation and Nasal Spray Generic Drugs Market 

Asthma is a major noncommunicable disease (NCD). It affects both children and adults and is the most common chronic disease among children. In the United States, asthma is more common in adult women than in adult men. According to the CDC 2020 report, approximately 25 million Americans suffer from asthma. Asthma affects around 20 million people in the United States aged 18 and over. Furthermore, according to AAFA, approximately 25 million people had asthma in 2021. Also, around 5 million American youngsters had asthma in 2021.

North America is Expected to Witness a Growth in the Inhalation and Nasal Spray Generic Drugs Market During the Forecast Period 

The North American inhalation and nasal spray generic drugs market is anticipated to have a significant share of the global market owing to the increasing burden of asthma and COPD coupled with well-established healthcare infrastructure and rising awareness. According to the Government of Canada report, chronic obstructive pulmonary disease (COPD) affected 453,700 and 488,100 people in 2019 and 2020, accounting for 7.2% and 7.5% of the total population, respectively. Hence increasing number of chronic respiratory diseases in the North American region is a driving factor for the utilization of nasal and inhalational generic drugs, thereby boosting the market growth.  Furthermore, the presence of key market players and the advancement of product technologies are fuelling the region's market growth. For instance, in March 2021, in Mexico and the United States, AstraZeneca PLC started a Phase III clinical trial to assess the efficacy and safety of budesonide/glycopyrronium/formoterol inhalers in adults and adolescents with severe asthma inadequately controlled with the standard of care. The trial is expected to be completed in September 2023.

Nasal Spray Market Table

Get Complete Analysis Of The Report - Download Free Sample PDF

Nasal Spray Market Competitive Landscape:

The market is fragmented and consists of several major players. The key players are concentrating on innovations and advancements in inhalation and nasal spray generic drugs, which are predicted to enhance competition in the market. Few players now dominate the industry due to adopting new strategies. Many companies are concentrating on mergers, acquisitions, and collaboration to increase their products' regional availability.

Key Players :

  • Akorn Incorporated
  • Apotex
  • Beximco Pharma
  • Cipla Inc.
  • Hikma (Roxane)
  • Mylan N.V.
  • Novartis AG (Sandoz)
  • Sun Pharma (Ranbaxy)
  • Teva Pharmaceuticals

Recent Developments: 

1) August 2022: Lupin received approval from the FDA for Formoterol Fumarate Inhalation Solution, used to treat chronic obstructive pulmonary disease symptoms. The company received approval from the USFDA for the generic version of Mylan Specialty's Perforomist Inhalation Solution.

2) March 2022: Viatris Inc., in partnership with Kindeva, received its first FDA approval for the generic version of Symbicort Inhalation Aerosol, Breyna (Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol), which is used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).



Frequently Asked Questions (FAQ) :

Q1. What is the current Nasal Spray Market size?

The Nasal Spray Market was currently valued at USD 10.7 billion.

Q2. What is the Growth Rate of the Nasal Spray Market?

Nasal Spray Market is registering a CAGR of 6.1% over the forecast period.

Q3. Which is the leading Component Segment in the Nasal Spray Market?

Asthma is the leading Component Segment in the Nasal Spray Market.

Q4. Which Region is expected to hold the highest Market share?

North American region is expected to hold the highest Market share.

INTRODUCTION            
    Study Assumptions and Market Definition        
    Scope of the Study        
RESEARCH METHODOLOGY            
EXECUTIVE SUMMARY            
MARKET DYNAMICS            
    Market Overview        
    Market Drivers        
        Growth and Innovations in the Pharmaceutical Industry for the Manufacturing of Nasal Spray Products Owing to a Massive Pool of Health-Conscious Consumers    
        The Increasing Prevalence of Asthma and COPD and The Availability of Low-Cost Generic Drugs Are Also Significant Factors Driving The Market Growth.     
    Market Restraints        
        Strict Government Regulations Associated with Generic Respiratory Drugs Restrain    
    Porter's Five Force Analysis        
        Threat of New Entrants    
        Bargaining Power of Buyers/Consumers    
        Bargaining Power of Suppliers    
        Threat of Substitute Products    
        Intensity of Competitive Rivalry    
MARKET SEGMENTATION (Market Size by Value - USD million)            
    By Drug Class        
        Corticosteroids    
        Bronchodilators    
        Antihistamines    
        Decongestant Sprays    
        Other Drug Type    
    By Application        
        Asthma    
        COPD    
        Allergic Rhinitis    
        Other Application    
    Geography        
        North America    
            United States
            Canada
            Mexico
        Europe    
            Germany
            United Kingdom
            France
            Italy
            Spain
            Rest of Europe
        Asia-Pacific    
            China
            Japan
            India
            Australia
            South Korea
            Rest of Asia-Pacific
        Middle East and Africa    
            GCC
            South Africa
            Rest of Middle East and Africa
        South America    
            Brazil
            Argentina
            Rest of South America
COMPETITIVE LANDSCAPE            
    Company Profiles        
        Akorn Incorporated    
        Apotex, Beximco Pharma    
        Cipla Inc.    
        Hikma (Roxane)    
        Mylan N.V.    
        Novartis AG (Sandoz)    
MARKET OPPORTUNITIES AND FUTURE TRENDS            

Request for List of Figure


Research Process

Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.

In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization

FIGURE 1: DLR RESEARH PROCESS

research-methodology1

Primary Research

Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.

In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.

It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.

Secondary Research

Secondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.

Market Size Estimation

Both, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.

Forecast Model

research-methodology2